Research On The Strategy Of Pharmaceuticals Enterprise KY Group

KY Group Co. Ltd. is a comprehensive pharmaceuticals group, whose leadingproducts are corticosteroid API, medical amino acids API, drugs for external use andcardiovascular diseases and antitumor drugs. It is the largest Asian corticosteroid APIand the largest domestic medical amino acids API production and sales enterprise.With the advancement of health care policies and the rapid development of medicalindustry, the competition is becoming increasingly fierce; thus, KY is confronted witha series of new challenges. After a few years of rapid progress, the Group has abottle-neck, which slows down the development rate.Therefore, how to consolidate and develop the present strengths and seek forspace for further advancement has become the major concern of KY Group.Based on the actual conditions of KY Group, this article first analyzes the outermacro environment, using PEST analytical model and then applying the fivecompeting force model of professor Michael e. Baud, analyzes in details the innerorganizational cadre, manufacturing technology, innovative ability, human resourcesand sales conditions of the corporation, which makes the advantages anddisadvantages of the corporation’s internal environment clear, and analyzes themarket demand of the pharmaceuticals industry, too. What’s more, with the SWOTanalytical method, it makes a strategically practical scheme for the corporation. Basedon synthetically analysis, it makes generic competitive strategies to be carried out inthe corporation. To conclude, the art states the principles and measures to carry outthe development strategies in the enterprise.What the article researches will help to further understand future directions of thedevelopment of KY, to rationally adjust and distribute internal and external resources,to increase the strengths and shorten the inferiority with other enterprises. Also, itcontributes to grasping and making the most of market opportunities and avoidingrisks, gaining rapid, healthy and sustainable development of KY. Meanwhile, theproblems facing KY signify those in the industry, and therefore other pharmaceuticalscorporations will benefit from the research as well.Furthermore, the article puts forward the idea of Preparation from own API, andown producing preparation API, which will contribute to opening up the upriver anddownstream of the pharmaceuticals industry and prolonging the industry chain,raising the profits of the products.